The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia

Sarolta Nahajevszky, H. Andrikovics, Arpad Batai, Emma Adam, Andras Bors, Judit Csomor, Laszlo Gopcsa, Magdalena Koszarska, Andras Kozma, Nora Lovas, Sandor Lueff, Zoltan Matrai, Nora Meggyesi, Janos Sinko, Andrea Sipos, Andrea Varkonyi, Sandor Fekete, A. Tordai, Tamas Masszil

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has been reported to be associated with an inherited predisposition to myeloproliferative neoplasms, and also to acute myeloid leukemia with normal karyotype. The aim of this study was to assess the prognostic impact of the 46/1 haplotype on disease characteristics and treatment outcome in acute myeloid leukemia. Design and Methods Janus kinase 2 rs12343867 single nucleotide polymorphism tagging the 46/1 haplotype was genotyped by LightCycler technology applying melting curve analysis with the hybridization probe detection format in 176 patients with acute myeloid leukemia under 60 years diagnosed consecutively and treated with curative intent. Results The morphological subtype of acute myeloid leukemia with maturation was less frequent among 46/1 carriers than among non-carriers (5.6% versus 17.2%, P=0.018, cytogenetically normal subgroup: 4.3% versus 20.6%, P=0.031), while the morphological distribution shifted towards the myelomonocytoid form in 46/1 haplotype carriers (28.1% versus 14.9%, P=0.044, cytogenetically normal subgroup: 34.0% versus 11.8%, P=0.035). In cytogenetically normal cases of acute myeloid leukemia, the 46/1 carriers had a considerably lower remission rate (78.7% versus 94.1%, P=0.064) and more deaths in remission or in aplasia caused by infections (46.8% versus 23.5%, P=0.038), resulting in the 46/1 carriers having shorter disease-free survival and overall survival compared to the 46/1 non-carriers. In multivariate analysis, the 46/1 haplotype was an independent adverse prognostic factor for disease-free survival (P=0.024) and overall survival (P=0.024) in patients with a normal karyotype. Janus kinase 2 46/1 haplotype had no impact on prognosis in the subgroup with abnormal karyotype. Conclusions Janus kinase 2 46/1 haplotype influences morphological distribution, increasing the predisposition towards an acute myelomonocytoid form. It may be a novel, independent unfavorable risk factor in acute myeloid leukemia with a normal karyotype.

Original languageEnglish
Pages (from-to)1613-1618
Number of pages6
JournalHaematologica
Volume96
Issue number11
DOIs
Publication statusPublished - Nov 1 2011

Fingerprint

Janus Kinase 2
Acute Myeloid Leukemia
Haplotypes
Karyotype
Disease-Free Survival
Abnormal Karyotype
Survival
Freezing
Single Nucleotide Polymorphism
Multivariate Analysis
Technology

Keywords

  • 46/1 haplotype
  • Acute myeloid leukemia
  • Janus Kinase 2
  • Prognosis

ASJC Scopus subject areas

  • Hematology

Cite this

The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia. / Nahajevszky, Sarolta; Andrikovics, H.; Batai, Arpad; Adam, Emma; Bors, Andras; Csomor, Judit; Gopcsa, Laszlo; Koszarska, Magdalena; Kozma, Andras; Lovas, Nora; Lueff, Sandor; Matrai, Zoltan; Meggyesi, Nora; Sinko, Janos; Sipos, Andrea; Varkonyi, Andrea; Fekete, Sandor; Tordai, A.; Masszil, Tamas.

In: Haematologica, Vol. 96, No. 11, 01.11.2011, p. 1613-1618.

Research output: Contribution to journalArticle

Nahajevszky, S, Andrikovics, H, Batai, A, Adam, E, Bors, A, Csomor, J, Gopcsa, L, Koszarska, M, Kozma, A, Lovas, N, Lueff, S, Matrai, Z, Meggyesi, N, Sinko, J, Sipos, A, Varkonyi, A, Fekete, S, Tordai, A & Masszil, T 2011, 'The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia', Haematologica, vol. 96, no. 11, pp. 1613-1618. https://doi.org/10.3324/haematol.2011.043885
Nahajevszky, Sarolta ; Andrikovics, H. ; Batai, Arpad ; Adam, Emma ; Bors, Andras ; Csomor, Judit ; Gopcsa, Laszlo ; Koszarska, Magdalena ; Kozma, Andras ; Lovas, Nora ; Lueff, Sandor ; Matrai, Zoltan ; Meggyesi, Nora ; Sinko, Janos ; Sipos, Andrea ; Varkonyi, Andrea ; Fekete, Sandor ; Tordai, A. ; Masszil, Tamas. / The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia. In: Haematologica. 2011 ; Vol. 96, No. 11. pp. 1613-1618.
@article{05d2609a3bad42acaa45c9cafd6012eb,
title = "The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia",
abstract = "Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has been reported to be associated with an inherited predisposition to myeloproliferative neoplasms, and also to acute myeloid leukemia with normal karyotype. The aim of this study was to assess the prognostic impact of the 46/1 haplotype on disease characteristics and treatment outcome in acute myeloid leukemia. Design and Methods Janus kinase 2 rs12343867 single nucleotide polymorphism tagging the 46/1 haplotype was genotyped by LightCycler technology applying melting curve analysis with the hybridization probe detection format in 176 patients with acute myeloid leukemia under 60 years diagnosed consecutively and treated with curative intent. Results The morphological subtype of acute myeloid leukemia with maturation was less frequent among 46/1 carriers than among non-carriers (5.6{\%} versus 17.2{\%}, P=0.018, cytogenetically normal subgroup: 4.3{\%} versus 20.6{\%}, P=0.031), while the morphological distribution shifted towards the myelomonocytoid form in 46/1 haplotype carriers (28.1{\%} versus 14.9{\%}, P=0.044, cytogenetically normal subgroup: 34.0{\%} versus 11.8{\%}, P=0.035). In cytogenetically normal cases of acute myeloid leukemia, the 46/1 carriers had a considerably lower remission rate (78.7{\%} versus 94.1{\%}, P=0.064) and more deaths in remission or in aplasia caused by infections (46.8{\%} versus 23.5{\%}, P=0.038), resulting in the 46/1 carriers having shorter disease-free survival and overall survival compared to the 46/1 non-carriers. In multivariate analysis, the 46/1 haplotype was an independent adverse prognostic factor for disease-free survival (P=0.024) and overall survival (P=0.024) in patients with a normal karyotype. Janus kinase 2 46/1 haplotype had no impact on prognosis in the subgroup with abnormal karyotype. Conclusions Janus kinase 2 46/1 haplotype influences morphological distribution, increasing the predisposition towards an acute myelomonocytoid form. It may be a novel, independent unfavorable risk factor in acute myeloid leukemia with a normal karyotype.",
keywords = "46/1 haplotype, Acute myeloid leukemia, Janus Kinase 2, Prognosis",
author = "Sarolta Nahajevszky and H. Andrikovics and Arpad Batai and Emma Adam and Andras Bors and Judit Csomor and Laszlo Gopcsa and Magdalena Koszarska and Andras Kozma and Nora Lovas and Sandor Lueff and Zoltan Matrai and Nora Meggyesi and Janos Sinko and Andrea Sipos and Andrea Varkonyi and Sandor Fekete and A. Tordai and Tamas Masszil",
year = "2011",
month = "11",
day = "1",
doi = "10.3324/haematol.2011.043885",
language = "English",
volume = "96",
pages = "1613--1618",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "11",

}

TY - JOUR

T1 - The prognostic impact of germline 46/1 haplotype of Janus Kinase 2 in cytogenetically normal acute myeloid leukemia

AU - Nahajevszky, Sarolta

AU - Andrikovics, H.

AU - Batai, Arpad

AU - Adam, Emma

AU - Bors, Andras

AU - Csomor, Judit

AU - Gopcsa, Laszlo

AU - Koszarska, Magdalena

AU - Kozma, Andras

AU - Lovas, Nora

AU - Lueff, Sandor

AU - Matrai, Zoltan

AU - Meggyesi, Nora

AU - Sinko, Janos

AU - Sipos, Andrea

AU - Varkonyi, Andrea

AU - Fekete, Sandor

AU - Tordai, A.

AU - Masszil, Tamas

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has been reported to be associated with an inherited predisposition to myeloproliferative neoplasms, and also to acute myeloid leukemia with normal karyotype. The aim of this study was to assess the prognostic impact of the 46/1 haplotype on disease characteristics and treatment outcome in acute myeloid leukemia. Design and Methods Janus kinase 2 rs12343867 single nucleotide polymorphism tagging the 46/1 haplotype was genotyped by LightCycler technology applying melting curve analysis with the hybridization probe detection format in 176 patients with acute myeloid leukemia under 60 years diagnosed consecutively and treated with curative intent. Results The morphological subtype of acute myeloid leukemia with maturation was less frequent among 46/1 carriers than among non-carriers (5.6% versus 17.2%, P=0.018, cytogenetically normal subgroup: 4.3% versus 20.6%, P=0.031), while the morphological distribution shifted towards the myelomonocytoid form in 46/1 haplotype carriers (28.1% versus 14.9%, P=0.044, cytogenetically normal subgroup: 34.0% versus 11.8%, P=0.035). In cytogenetically normal cases of acute myeloid leukemia, the 46/1 carriers had a considerably lower remission rate (78.7% versus 94.1%, P=0.064) and more deaths in remission or in aplasia caused by infections (46.8% versus 23.5%, P=0.038), resulting in the 46/1 carriers having shorter disease-free survival and overall survival compared to the 46/1 non-carriers. In multivariate analysis, the 46/1 haplotype was an independent adverse prognostic factor for disease-free survival (P=0.024) and overall survival (P=0.024) in patients with a normal karyotype. Janus kinase 2 46/1 haplotype had no impact on prognosis in the subgroup with abnormal karyotype. Conclusions Janus kinase 2 46/1 haplotype influences morphological distribution, increasing the predisposition towards an acute myelomonocytoid form. It may be a novel, independent unfavorable risk factor in acute myeloid leukemia with a normal karyotype.

AB - Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has been reported to be associated with an inherited predisposition to myeloproliferative neoplasms, and also to acute myeloid leukemia with normal karyotype. The aim of this study was to assess the prognostic impact of the 46/1 haplotype on disease characteristics and treatment outcome in acute myeloid leukemia. Design and Methods Janus kinase 2 rs12343867 single nucleotide polymorphism tagging the 46/1 haplotype was genotyped by LightCycler technology applying melting curve analysis with the hybridization probe detection format in 176 patients with acute myeloid leukemia under 60 years diagnosed consecutively and treated with curative intent. Results The morphological subtype of acute myeloid leukemia with maturation was less frequent among 46/1 carriers than among non-carriers (5.6% versus 17.2%, P=0.018, cytogenetically normal subgroup: 4.3% versus 20.6%, P=0.031), while the morphological distribution shifted towards the myelomonocytoid form in 46/1 haplotype carriers (28.1% versus 14.9%, P=0.044, cytogenetically normal subgroup: 34.0% versus 11.8%, P=0.035). In cytogenetically normal cases of acute myeloid leukemia, the 46/1 carriers had a considerably lower remission rate (78.7% versus 94.1%, P=0.064) and more deaths in remission or in aplasia caused by infections (46.8% versus 23.5%, P=0.038), resulting in the 46/1 carriers having shorter disease-free survival and overall survival compared to the 46/1 non-carriers. In multivariate analysis, the 46/1 haplotype was an independent adverse prognostic factor for disease-free survival (P=0.024) and overall survival (P=0.024) in patients with a normal karyotype. Janus kinase 2 46/1 haplotype had no impact on prognosis in the subgroup with abnormal karyotype. Conclusions Janus kinase 2 46/1 haplotype influences morphological distribution, increasing the predisposition towards an acute myelomonocytoid form. It may be a novel, independent unfavorable risk factor in acute myeloid leukemia with a normal karyotype.

KW - 46/1 haplotype

KW - Acute myeloid leukemia

KW - Janus Kinase 2

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=80355126548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80355126548&partnerID=8YFLogxK

U2 - 10.3324/haematol.2011.043885

DO - 10.3324/haematol.2011.043885

M3 - Article

C2 - 21791467

AN - SCOPUS:80355126548

VL - 96

SP - 1613

EP - 1618

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 11

ER -